These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 7000899)

  • 1. Cell surface DNA in immunosuppression in AKR leukemia.
    Russell JL; Golub ES
    J Immunol; 1980 Nov; 125(5):2328-33. PubMed ID: 7000899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia in AKR mice: a defined suppressor cell population expressing membrane-associated DNA.
    Russell JL; Golub ES
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):6211-4. PubMed ID: 366615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sca1(+)/Mac1(+) nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro.
    Johnson BD; Hanke CA; Becker EE; Truitt RL
    Cell Immunol; 1998 Nov; 189(2):149-59. PubMed ID: 9790729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal immunization with a soluble TCR-Ig chimeric protein: long term, V beta-8 family-specific suppression of T cells by maternally transferred antibodies.
    McKeever U; Khandekar S; Jesson M; Newcomb J; Gregory P; Naylor J; Haskins K; Jones B
    J Immunol; 1997 Dec; 159(12):5936-45. PubMed ID: 9550391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemia in AKR mice. I. Effects of leukemic cells on antibody-forming potential of syngeneic and allogeneic normal cells.
    Roman JM; Golub ES
    J Exp Med; 1976 Mar; 143(3):482-96. PubMed ID: 942993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antileukemic effect of interleukin-2 on spontaneous development of leukemia after H-2-compatible allogenic bone marrow transplantation in AKR/J mice.
    Hashino S
    Hokkaido Igaku Zasshi; 1994 May; 69(3):601-13. PubMed ID: 7927184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the requirements for cognate T cell help for IgG anti-double-stranded DNA antibody production in vitro: T helper-derived lymphokines replace T cell cloned lines for B cells from NZB.H-2bm12 but not B6.H-2bm12 mice.
    Cawley D; Chiang BL; Naiki M; Ansari AA; Gershwin ME
    J Immunol; 1993 Mar; 150(6):2467-77. PubMed ID: 8450223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triggering of leukemia in thymectomized AKR mice by a membrane fraction of thymic stroma.
    Fournier M; Potworowski EF
    Thymus; 1983 Mar; 5(2):89-94. PubMed ID: 6602405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of IFN-gamma and transforming growth factor-beta in graft-vs-host reaction-associated immunosuppression.
    Huchet R; Bruley-Rosset M; Mathiot C; Grandjon D; Halle-Pannenko O
    J Immunol; 1993 Mar; 150(6):2517-24. PubMed ID: 8450227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Ly-1+ B-cell populations and IgH rearrangements in "normal" spleens and in lymphomas of AKR/J and AKR Fv-1b mice.
    Rosner A; Peled A; Haran-Ghera N; Canaani E
    Cancer Res; 1993 May; 53(9):2147-53. PubMed ID: 7683252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory role of gamma delta T cells in uterine intraepithelial lymphocytes in maternal antifetal immune response.
    Suzuki T; Hiromatsu K; Ando Y; Okamoto T; Tomoda Y; Yoshikai Y
    J Immunol; 1995 May; 154(9):4476-84. PubMed ID: 7722304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of DNA synthesis in vitro in normal and leukemic spleen cells after administration of a lyophilized aqueous extract of normal spleen tissue].
    Svirnovskiĭ AI; Shimanskaia TV; Ageĭchik VM; Levin VI
    Biull Eksp Biol Med; 1981 Jun; 91(6):715-7. PubMed ID: 7272490
    [No Abstract]   [Full Text] [Related]  

  • 13. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
    Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K
    Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 Th2 cells do not functionally suppress CTL generation in neonatal tolerant mice.
    Gao Q; Chen N; Field EH
    Transplantation; 1995 Dec; 60(11):1260-8. PubMed ID: 8525520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine leukemia. Proposed role for gangliosides in immune suppression.
    Krishnaraj R; Lengle EE; Kemp RG
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):89-98. PubMed ID: 6211363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice with the xid mutation lack the regulatory antibodies that are necessary for the induction of contrasuppression.
    Simpson SD; Ernst PB
    Cell Immunol; 1995 Aug; 164(1):126-32. PubMed ID: 7634344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2 reduces graft-versus-host disease and preserves a graft-versus-leukemia effect by selectively inhibiting CD4+ T cell activity.
    Sykes M; Abraham VS; Harty MW; Pearson DA
    J Immunol; 1993 Jan; 150(1):197-205. PubMed ID: 8093257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium yoelii in mice: antigen reactivity of CD4- and CD8-bearing T cells.
    Lucas B; Engel A; Camus D; Haque A
    Cell Immunol; 1993 Aug; 150(1):59-71. PubMed ID: 8102089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.